<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of perinatal <z:hpo ids='HP_0001297'>stroke</z:hpo> is approximately 0.025% </plain></SENT>
<SENT sid="1" pm="."><plain>About two thirds of these patients develop long-lasting neurological deficits </plain></SENT>
<SENT sid="2" pm="."><plain>Preconditioning-induced neuroprotection, a phenomenon in which application of a stimulus induces brain ischemic tolerance, is investigated to improve outcome after a perinatal <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We applied prenatal <z:mp ids='MP_0005039'>hypoxia</z:mp> to fetuses by exposing 22-day pregnant mother rats to 15% oxygen for 30 min and subjected newborns with or without this prenatal <z:mp ids='MP_0005039'>hypoxia</z:mp> to <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> 48 h later </plain></SENT>
<SENT sid="4" pm="."><plain>Newborns with the prenatal <z:mp ids='MP_0005039'>hypoxia</z:mp> had a lower mortality rate, less brain tissue and <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> and fewer active caspase 3 (an indicator for cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>) positive brain cells than newborns with the <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> only </plain></SENT>
<SENT sid="5" pm="."><plain>This neuroprotection was abolished by an inhibitor of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) </plain></SENT>
<SENT sid="6" pm="."><plain>The expression of iNOS proteins but not endothelial and neuronal NOS proteins was increased by the prenatal <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, the prenatal <z:mp ids='MP_0005039'>hypoxia</z:mp>-induced neuroprotection may be iNOS-dependent </plain></SENT>
</text></document>